CompletedNot Applicable

A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT

South Korea37 participantsStarted 2018-05-09

Plain-language summary

It is well known that Chitosan oligosaccharide is low molecular weight and water soluble and chitosan oligosaccharide has been shown to reduce blood cholesterol and blood pressure, increase immunity, and enhance antitumor properties. the effect of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with normal blood glucose, impaired fasting glucose and impaired glucose tolerance.

Who can participate

Age range

20 Years – 74 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Normal Blood Glucose (fasting blood sugar below 100mg/dl, two hours after meals below 140mg/dl) * Impaired Fasting Glucose (fasting blood sugar 100-125mg/dl) * Impaired Glucose Tolerance (two hours after meals 140-199mg/dl) Exclusion Criteria: * history/presence of diabetes mellitus (including oral hypoglycaemic agent and insulin) * history of serious hypoglycemia * history of serious cardiovascular, cerebrovascular disease, pulmonary, gastrointestinal, hepatic, renal and/or haematological disease * uncontrolled blood pressure (blood pressure level more than 140/90mmHg) * history/presence of alcoholism, drug addiction, etc. * taking a regulation of blood glucose medications within 1 month before study * participation other intervention studies within 1 months before study * history of diagnosed with cancer, cancer surgery and hospitalization * women who are pregnant or desire to become pregnant during the study period * having any other medical condition which, in the opinion of the investigator, could interfere with participation in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Glucose levels

Timeframe: 2 hours

Trial details

NCT IDNCT03650023

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-25

View on ClinicalTrials.gov More Normal trials